[GHK-Cu Consultation guide](/)
A question is a good place to start.

The guide index

- [Start here](/)

- [Creams & injections](/first-read/)

- [FDA status](/common-questions/)

- [What the research says](/question-desk/)

- [Finding care](/care-notes/)

- [Costs & your worksheet](/paying-for-care/)

- [Red flags & open gaps](/red-flags/)

- [Further reading](/further-reading/)

Bring a question.
Leave the rush behind.

- [Start here](/)

- Red flags & open gaps

# Know what a confident pitch leaves out

Claims and gap notes · September 30, 2026

A sales page may promise better skin without saying whether it offers a cream or a shot. Ask who makes it and what studies in people support that promise.

The Food and Drug Administration oversees drugs in the US; its initials are FDA.
Signal to examine
What it leaves out
What to ask
Approval by code
As of September 30, 2026, a National Drug Code (NDC) identifies a listed drug product but does not prove FDA approval.
Can you show the approval for this exact medicine?
Skin results used for injections
Skin findings cannot establish benefits from injected GHK-Cu in people.
Did the study test the cream or shot you are offering, in people?
An unnamed pharmacy
The service’s name may not tell you which pharmacy made a medicine to order.
What is the pharmacy’s full name for the licence check?

These checks test the claim. They do not certify a product or a care business.

## “For research use only” does not mean treatment

In letters checked September 26, 2026, the FDA accused specific companies of selling unapproved drugs despite labels such as “for research use only”.

Those words mean the product is labelled for research. They do not erase claims on the seller’s page about treating people.

The Federal Trade Commission warns that seals that look official and promises of refunds may be fake.

As of September 26, 2026, federal law does not allow a prescription medicine to be supplied without a valid prescription.

## The FDA concern and the missing information

On a page marked current April 22, 2026, FDA flags possible reactions by the body’s defence system to made-to-order GHK-Cu injections.

The FDA says the peptide could stick together in clumps or contain unwanted material. These could make the body’s defence system react against it.

The FDA also says there is too little information from people to judge safety well.

That is the FDA’s stated concern, rather than a report proving a particular reaction happened.

### The missing information belongs in the conversation

Small skin-product studies are too small to catch rare problems.

There is no FDA-reviewed information on use with other medicines or in pregnancy, as of September 30, 2026.

Wilson disease is an inherited condition that makes copper build up in the body.

GHK-Cu has not been studied in people with that condition, as of September 30, 2026.

That gap is a question to raise with a doctor; it is not a documented harm from GHK-Cu.

## If severe symptoms are happening now

Trouble breathing or tongue swelling may be signs of a severe allergic reaction.

The US National Library of Medicine provides the health guide MedlinePlus, which advises emergency help for severe allergy symptoms.

These are general urgent-help signs, not a list of proven GHK-Cu reactions.

[Next read: Further reading →](/further-reading/)

Read this guide for questions to ask about GHK-Cu care. It shares information; this guide neither runs a clinic nor sells treatments.

[Further reading](/further-reading/) [Read as plain text](/red-flags/index.md)